TrialDrug design, development and therapy2015

Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye.

Xiaodan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.